Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by TD Asset Management Inc.
TD Asset Management Inc. cut its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 939,610 shares of the pharmacy operator’s stock after selling 7,489 shares during the period. TD Asset Management Inc. owned approximately 0.09% of Walgreens Boots Alliance worth $78,034,000 at the end of the most recent reporting period.
A number of other large investors have also recently modified their holdings of WBA. Hudock Capital Group LLC boosted its position in Walgreens Boots Alliance by 0.4% in the first quarter. Hudock Capital Group LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $108,000 after buying an additional 5 shares during the period. Glassman Wealth Services boosted its position in Walgreens Boots Alliance by 0.6% in the fourth quarter. Glassman Wealth Services now owns 2,898 shares of the pharmacy operator’s stock valued at $240,000 after buying an additional 18 shares during the period. WealthTrust Arizona LLC boosted its position in Walgreens Boots Alliance by 0.4% in the first quarter. WealthTrust Arizona LLC now owns 5,243 shares of the pharmacy operator’s stock valued at $435,000 after buying an additional 19 shares during the period. Massmutual Trust Co. FSB ADV boosted its position in Walgreens Boots Alliance by 0.9% in the first quarter. Massmutual Trust Co. FSB ADV now owns 3,216 shares of the pharmacy operator’s stock valued at $267,000 after buying an additional 30 shares during the period. Finally, Truepoint Inc. boosted its position in Walgreens Boots Alliance by 0.4% in the first quarter. Truepoint Inc. now owns 8,575 shares of the pharmacy operator’s stock valued at $712,000 after buying an additional 38 shares during the period. 61.16% of the stock is owned by hedge funds and other institutional investors.
Shares of Walgreens Boots Alliance, Inc. (NASDAQ WBA) traded up 0.02% during trading on Thursday, hitting $81.05. 4,666,526 shares of the stock traded hands. Walgreens Boots Alliance, Inc. has a 1-year low of $75.18 and a 1-year high of $88.00. The stock has a market cap of $86.73 billion, a price-to-earnings ratio of 20.47 and a beta of 1.25. The stock has a 50 day moving average price of $78.82 and a 200-day moving average price of $82.40.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, beating analysts’ consensus estimates of $1.30 by $0.03. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The business had revenue of $30.12 billion for the quarter, compared to analysts’ expectations of $29.72 billion. During the same period last year, the business earned $1.18 earnings per share. The business’s quarterly revenue was up 2.1% on a year-over-year basis. Equities analysts forecast that Walgreens Boots Alliance, Inc. will post $5.01 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th will be given a dividend of $0.40 per share. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. This represents a $1.60 dividend on an annualized basis and a yield of 1.97%. The ex-dividend date of this dividend is Wednesday, August 16th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 37.78%.
Walgreens Boots Alliance announced that its board has authorized a share repurchase plan on Wednesday, April 5th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the pharmacy operator to reacquire shares of its stock through open market purchases. Shares buyback plans are usually an indication that the company’s board believes its stock is undervalued.
WARNING: This piece of content was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/03/td-asset-management-inc-has-78-03-million-position-in-walgreens-boots-alliance-inc-nasdaqwba-updated-updated-updated.html.
Several brokerages recently commented on WBA. Needham & Company LLC set a $94.00 target price on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Monday, July 17th. BidaskClub upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Thursday. Pivotal Research set a $85.00 target price on shares of Walgreens Boots Alliance and gave the stock a “hold” rating in a report on Sunday, July 2nd. Guggenheim restated a “buy” rating on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. Finally, Goldman Sachs Group, Inc. (The) restated a “neutral” rating and set a $77.00 target price (down previously from $89.00) on shares of Walgreens Boots Alliance in a report on Wednesday, June 28th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and fourteen have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $90.69.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total transaction of $218,305.44. Following the transaction, the director now directly owns 19,151 shares in the company, valued at $1,528,058.29. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 13.50% of the stock is owned by company insiders.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.